• $1.5m in international sales revenue for FY25, up 69% vs PCP
• Secured strategic distribution partnerships in Ireland, New Zealand, and Canada
• Positioned for significant international growth and expansion in FY26

Biome Australia Limited (ASX: BIO) has reported strong international sales growth and secured several significant new health retail and distribution deals in key markets during FY25. The company achieved approximately $1.5 million in international sales revenue, representing a 69% increase over the previous financial year. Biome has secured strategic partnerships with prominent distributors in Ireland, New Zealand, and Canada, including Uniphar, Propharma (EBOS), Pure Pharmacy Group, Healthy Planet Group, Nature's Emporium, and Nature's Signature. These partnerships are expected to significantly boost Biome's international sales volume and brand recognition, further establishing its position as a leading player in the global health and wellness sector. Biome remains committed to identifying and entering new markets, driven by a strong desire to make its innovative health solutions accessible to a wider international audience. The company is now strategically positioned for significant international growth and expansion in FY26, leveraging these new distribution channels to access thousands of additional pharmacy and health food locations.

Biome is forecasting continued strong international sales growth, with the new distribution partnerships expected to significantly boost sales volume and brand recognition in FY26.

Biome is well-positioned for significant international expansion in FY26, with new distribution partnerships in Ireland, New Zealand, and Canada providing access to thousands of additional pharmacy and health food locations.